Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Trump administration finalizes kidney care rules

CMS has finalized changes to Medicare payment methodologies that aim to improve care for kidney care patients.

Thumbnail

Private equity has a role in increasing healthcare prices

The healthcare space has seen an influx of investment from private equity groups looking to innovate the market, but the role of these investors could also be pushing healthcare prices higher.

Thumbnail

Pelosi plan to lower drug prices faces political challenges

House Speaker Nancy Pelosi’s (D-CA) bill to lower drug prices is facing new challenges as congressional Democrats debate changes to the plan, The Hill reported.

Thumbnail

Walgreens changes in-store clinic strategy with closures, partnerships

Walgreens is switching up its approach to in-store clinics, closing the clinics it operates and keeping those run by other health systems.

Thumbnail

Americans are split on healthcare reform plans

Americans are split across healthcare reform options, according to a recent survey, revealing that many are dissatisfied with the current healthcare system but don’t agree on how to improve it.

Thumbnail

Some Americans avoid healthcare because they don’t understand insurance

Lack of understanding about healthcare insurance is impacting the health of Americans.

Thumbnail

States prep for loss of ACA

Several states are working on their own healthcare plans to preserve some coverage and provisions of the Affordable Care Act as the healthcare law makes its way through an appeals court and faces the real possibility of being overturned, The Wall Street Journal reported.

Thumbnail

AI’s effect on healthcare could be transformative—but it will need some help

As AI technologies continue to evolve, they could have a titanic impact on the health of people all over the world, improving patient outcomes and changing the way each and every person lives their life. It’s going to take more than just AI alone, however—there are a number of other factors to consider as well.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.